Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Definium Therapeutics | Buy | $78 | |
Abeona Therapeutics | Buy | $17 | |
Damora Therapeutics | Buy | $45 | |
Corcept Therapeutics | Buy | $165 | |
Contineum Therapeutics, Inc. Class A | Buy | $23 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 |
Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Definium Therapeutics | Buy | $78 | |
Abeona Therapeutics | Buy | $17 | |
Damora Therapeutics | Buy | $45 | |
Corcept Therapeutics | Buy | $165 | |
Contineum Therapeutics, Inc. Class A | Buy | $23 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 |